Robert Schwab

Robert Schwab is a physician currently completing his hematology-oncology fellowship at the Hospital of the University of Pennsylvania.12 He is affiliated with Penn Medicine, University of Pennsylvania Health System, where he has been a Fellow since June 2021.2

Education and Training

Dr. Schwab received his medical education from the University of Pennsylvania - Perelman School of Medicine, earning his Doctor of Medicine (M.D.) degree.2 He also holds a Master of Science (MS) in Translational Research from the University of Pennsylvania.2 Prior to his medical training, he completed his Bachelor of Arts (B.A.) in Biophysics and Biochemistry at Amherst College, graduating with a 3.8 GPA.2

Professional Experience

Medical Career::

• Currently a Fellow in Hematology and Medical Oncology at the University of Pennsylvania Health System (2021-2025)3
• Resident Physician at the University of Pennsylvania since June 20192

Research Experience::

• Research Specialist at the University of Pennsylvania's Carl June Laboratory since June 20132
• Focused on cancer immunotherapy and CAR T cell treatment
• Investigated novel applications of CAR T cell therapy, particularly for atherosclerosis

Entrepreneurship

In 2019, Dr. Schwab founded Cartio Therapeutics LLC, a biotech start-up aimed at developing cellular immunotherapy for cardiovascular disease.2

Achievements and Honors

Throughout his academic and professional career, Dr. Schwab has received several honors:

• John G. Clark Prize from the University of Pennsylvania (March 2015)2
• Graduated Cum Laude with Distinction from Amherst College (May 2013)2
• NESCAC All-Academic Honor (June 2013)2

Dr. Schwab's work spans clinical practice, research, and entrepreneurship, with a focus on advancing immunotherapy treatments for both cancer and cardiovascular diseases.